European Patent Bulletin 2012/09 - European Patent Office
European Patent Bulletin 2012/09 - European Patent Office European Patent Bulletin 2012/09 - European Patent Office
(A61K) I.1(1) COMPOSÉS, COMPOSITIONS ET MÉTHODES COMPRENANT DES DÉRIVÉS DU 1,3,4-OXADIAZOLE (71) Institute for OneWorld Health, 280 Utah Avenue, Suite 250, South San Francisco, CA 94080, US (72) RUSSELL, Michael Geoffrey Neil, Saffron Walden, Essex CB10 1XL, GB DOYLE, Kevin James, Saffron Walden, Essex CB10 1XL, GB (74) Gates, Marie Christina Esther, et al, Tomkins & Co. 5 Dartmouth Road, Dublin 6, IE A61K 31/41 → (51) A01N 43/82 A61K 31/415 → (51) A61K 9/51 A61K 31/415 → (51) A61K 31/215 A61K 31/415 → (51) C07D 231/14 A61K 31/415 → (51) C07D 231/40 A61K 31/4174 → (51) C07D 233/06 A61K 31/4178 → (51) C07D 403/14 A61K 31/4192 → (51) C07D 231/14 (51) A61K 31/42 (11) 2 421 529 A2* A61K 31/40 A61K 39/395 A61K 9/16 A61K 9/14 A61P 7/00 A61P 3/00 (25) En (26) En (21) 10767606.6 (22) 20.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2010/031675 20.04.2010 (87) WO 2010/123845 2010/43 28.10.2010 (88) 17.02.2011 (30) 21.04.2009 US 171151 P (54) AUF SIDEROPHORKONJUGAT BASIE- RENDE IMMUNOGENE ZUSAMMENSET- ZUNGEN UND IMPFSTOFFE SIDEROPHORE CONJUGATE IMMU- NOGENIC COMPOSITIONS AND VACCINES COMPOSITIONS IMMUNOGÉNIQUES À BASE DE CONJUGUÉ SIDÉROPHORE ET VACCINS (71) University of Florida Research Foundation, Inc., 223 Grinter Hall P.O. Box 115500, Gainesville, FL 32611-5500, US (72) BERGERON, Raymond, J., Gainesville FL 32604, US (74) Ilgart, Jean-Christophe, et al, BREVALEX 95 rue d'Amsterdam, 75378 Paris Cedex 8, FR A61K 31/42 → (51) A61K 31/185 A61K 31/42 → (51) C07D 231/14 (51) A61K 31/421 (11) 2 421 530 A1* A61K 9/14 A61P 21/02 (25) En (26) En (21) 10766517.6 (22) 23.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) AU 2010/000468 23.04.2010 (87) WO 2010/121324 2010/43 28.10.2010 (30) 24.04.2009 AU 2009901743 24.04.2009 US 172281 P (54) NEUE METAXALONFORMULIERUNG A NOVEL FORMULATION OF METAXALONE NOUVELLE FORMULATION DE MÉTAXA- LONE Europäisches Patentblatt European Patent Bulletin Bulletin européen des brevets (71) Iceutica Pty Ltd., 52 Fairfield Street, Mouth Hawthorn, WA 6016, AU (72) DODD, Aaron, Centennial Park New South Wales 2021, AU MEISER, Felix, Mount Claremont Western Australia 6010, AU NORRET, Marck, Darlington Western Australia 6070, AU RUSSELL, Adrian, Rivervale Western Australia 6103, AU BOSCH, H William, Bryn Mawr Pennsylvania 19010, US (74) Coehn, Markus, et al, Fish & Richardson P.C. Mies-van-der-Rohe-Strasse 8, 80807 München, DE A61K 31/421 → (51) A61K 9/14 A61K 31/421 → (51) A61K 9/51 (51) A61K 31/422 (11) 2 421 531 A1* A61P 15/02 A61P 31/04 A61P 13/02 A61P 15/00 A61K 9/00 A61K 9/06 A61K 9/20 (25) En (26) En (21) 10715790.1 (22) 19.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR AL BA ME RS (86) EP 2010/055090 19.04.2010 (87) WO 2010/121980 2010/43 28.10.2010 (30) 20.04.2009 EP 09158221 (54) VERWENDUNG VON NIFURATEL ZUR BE- HANDLUNG VON INFEKTIONEN DURCH ATOPOBIUM-SPEZIES USE OF NIFURATEL TO TREAT INFECTIONS CAUSED BY ATOPOBIUM SPECIES UTILISATION DE NIFURATEL POUR TRAITER DES INFECTIONS PROVOQUÉES PAR DES ESPÈCES ATOPOBIUM (71) POLICHEM S.A., 50 Val Fleuri, 1526 Luxembourg, LU (72) MAILLAND, Federico, CH-6900 Lugano, CH (74) Pistolesi, Roberto, et al, Dragotti & Associati Srl Via Nino Bixio, 7, 20129 Milano, IT A61K 31/426 → (51) A61K 31/404 A61K 31/427 → (51) A61K 38/16 A61K 31/433 → (51) A61K 31/155 A61K 31/4353 → (51) A61P 35/00 A61K 31/437 → (51) C07D 493/20 A61K 31/4375 → (51) C07D 471/04 (51) A61K 31/438 (11) 2 421 532 A2* A61P 13/10 A61P 11/00 (25) En (26) En (21) 09818115.9 (22) 01.10.2009 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2009/005441 01.10.2009 (87) WO 2010/039260 2010/14 08.04.2010 (88) 05.08.2010 (30) 02.10.2008 US 102135 P (54) SPIPERON-DERIVATE UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUN- GEN SPIPERONE DERIVATIVES AND METHODS OF TREATING DISORDERS DÉRIVÉS DE SPIPÉRONE ET MÉTHODES DE TRAITEMENT DE TROUBLES 40 Anmeldungen Applications Demandes (09/2012) 29.02.2012 (71) The Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, US (72) GUGGINO, William, B., Baltimore MD 21210, US SCHWIEBERT, Erik, M., Birmingham, AL 35203, US LIANG, Lihua, Baltimore MD 21212, US (74) Hiebl, Inge Elisabeth, Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer- Ring 15, 80539 München, DE A61K 31/44 → (51) C07D 401/12 A61K 31/4412 → (51) C07D 213/64 A61K 31/4439 → (51) A61K 31/215 A61K 31/4439 → (51) C07D 513/04 A61K 31/444 → (51) C07D 401/06 A61K 31/444 → (51) C07D 401/12 A61K 31/445 → (51) C07D 211/96 A61K 31/4468 → (51) A61K 31/00 A61K 31/4468 → (51) C07D 211/60 A61K 31/465 → (51) A61K 9/14 (51) A61K 31/47 (11) 2 421 533 A1* C07D 239/91 (25) En (26) En (21) 10714825.6 (22) 21.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2010/031870 21.04.2010 (87) WO 2010/123975 2010/43 28.10.2010 (30) 22.04.2009 US 171620 P (54) NEUE ENTZÜNDUNGSHEMMENDE MIT- TEL NOVEL ANTI-INFLAMMATORY AGENTS NOUVEAUX AGENTS ANTI-INFLAMMA- TOIRES (71) RESVERLOGIX CORP., 202, 279 Midpark Way S.E., Calgary, Alberta T2X 1M2, CA (72) HANSEN, Henrik, C., Calgary AB T2L 1E6, CA WAGNER, Gregory, S., Foster City CA 94404, US ATTWELL, Sarah, C., Calgary AB T3B 2K5, CA MCLURE, Kevin, G., Calgary AB T2W 4V4, CA KULIKOWSKI, Ewelina, B., Calgary AB T3H 4N9, CA (74) Vossius & Partner, Siebertstrasse 4, 81675 München, DE A61K 31/47 → (51) A61K 31/538 A61K 31/4709 → (51) A61K 9/14 A61K 31/4745 → (51) C07D 471/04 A61K 31/4747 → (51) C07D 471/10 A61K 31/485 → (51) A61K 9/50 (51) A61K 31/495 (11) 2 421 534 A1* A61K 9/08 A61P 25/00 A61P 25/22 A61P 25/24 A61P 25/28 (25) En (26) En (21) 10714164.0 (22) 16.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
(A61K) I.1(1) (86) DK 2010/050084 16.04.2010 (87) WO 2010/121621 2010/43 28.10.2010 (30) 24.04.2009 DK 200900531 24.04.2009 US 214540 (54) FLÜSSIGE FORMULIERUNGEN VON SAL- ZEN VON 1-[2-(2,4-DIMETHYLPHEN- YLSULFANYL)PHENYL]PIPERAZIN LIQUID FORMULATIONS OF SALTS OF 1- Ý2-(2,4-DIMETHYLPHENYLSULFANYL)- PHENYL¨PIPERAZINE FORMULATIONS LIQUIDES DE SELS DE 1-Ý2-(2,4-DIMÉTHYLPHÉNYLSUL- FANYL)- PHÉNYL¨PIPÉRAZINE (71) H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, DK (72) TREPPENDAHL, Svend, DK-2830 Virum, DK LOPEZ DE DIEGO, Heidi, DK-2850 Nærum, DK (74) Conrad, Lars Sparre, et al, H. Lundbeck A/S Ottiliavej 9, 2500 Valby, DK A61K 31/495 → (51) A61K 31/215 (51) A61K 31/496 (11) 2 421 535 A1* A61P 29/00 A61P 25/02 A61P 1/06 (25) En (26) En (21) 10714829.8 (22) 22.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR AL BA ME RS (86) US 2010/032100 22.04.2010 (87) WO 2010/124122 2010/43 28.10.2010 (30) 22.04.2009 US 171661 P (54) HETEROAROMATISCHE UND AROMATI- SCHE PIPERAZINYL-AZETIDINYL-AMIDE ALS MONOACYLGLYCEROL-LIPASE-IN- HIBITOREN HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHI- BITORS PIPÉRAZINYL AZÉTIDINYL AMIDES HÉTÉROAROMATIQUES ET AROMATI- QUES EN TANT QU'INHIBITEURS DE LA MONOACYLGLYCÉROL LIPASE (71) Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse, BE (72) FLORES, Christopher, M., Spring House PA 19477, US NELEN, Marina, I., Exton PA 19341, US NULTON, Erica, L., Exton PA 19341, US PROUTY, Stephen, PA 19104, US TODD, Matthew, Exton PA 19341, US ZHANG, Sui-Po, Exton PA 19341, US (74) Warner, James Alexander, et al, Carpmaels & Ransford One Southampton Row, London WC1B 5HA, GB A61K 31/496 → (51) A61K 9/51 A61K 31/496 → (51) C07D 205/04 A61K 31/496 → (51) C07D 401/06 A61K 31/496 → (51) C07D 401/10 A61K 31/496 → (51) C07D 401/12 A61K 31/496 → (51) C07D 405/06 A61K 31/496 → (51) C07D 417/04 A61K 31/496 → (51) C07D 417/12 A61K 31/4965 → (51) C07D 213/64 A61K 31/497 → (51) A61K 9/14 Europäisches Patentblatt European Patent Bulletin Bulletin européen des brevets A61K 31/4985 → (51) C07D 498/04 A61K 31/50 → (51) A01N 43/58 A61K 31/50 → (51) C07D 213/64 A61K 31/501 → (51) C07D 401/12 A61K 31/506 → (51) C07D 401/12 A61K 31/513 → (51) C07D 213/64 A61K 31/513 → (51) C07D 401/04 A61K 31/517 → (51) A61K 31/519 (51) A61K 31/519 (11) 2 421 536 A1* A61K 31/517 A61P 35/00 A61P 37/00 (25) En (26) En (21) 10715447.8 (22) 20.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2010/031794 20.04.2010 (87) WO 2010/123931 2010/43 28.10.2010 (30) 20.04.2009 US 171047 P (54) VERFAHREN ZUR BEHANDLUNG VON SOLIDEN TUMOREN METHODS OF TREATMENT FOR SOLID TUMORS PROCÉDÉS DE TRAITEMENT DE TUMEURS SOLIDES (71) Gilead Calistoga LLC, 333 Lakeside Drive, Foster City. CA 94404, US (72) PURI, Kamal, D., Foster City, CA 94404, US EVARTS, Jerry, B., Foster City, CA 94404, US LANNUTTI, Brian, Foster City, CA 94404, US GIESE, Neill, A., Foster City, CA 94404, US (74) Barton, Matthew Thomas, Forrester & Boehmert Pettenkoferstrasse 20-22, 80336 München, DE A61K 31/53 → (51) A61K 9/14 (51) A61K 31/535 (11) 2 421 537 A1* (25) En (26) En (21) 09829580.1 (22) 27.10.2009 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR AL BA RS (86) US 2009/062163 27.10.2009 (87) WO 2010/062578 2010/22 03.06.2010 (30) 15.09.2009 US 242432 P 15.05.2009 US 178517 P 27.10.2008 US 108568 P (54) PYRAZOLYLAMINOPYRIDINE ALS FAK- HEMMER PYRAZOLYLAMINOPYRIDINES AS INHI- BITORS OF FAK PYRAZOLYLAMINOPYRIDINES AU TITRE D'INHIBITEURS DE FAK (71) GlaxoSmithKline LLC, One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, US (72) ADAMS, Jerry, Leroy, Collegeville PA 19426, US FAITG, Thomas, H., Collegeville PA 19426, US JOHNSON, Neil, W., Collegeville PA 19426, US LIN, Hong, Collegeville PA 19426, US KASPAREC. Jiri, Collegeville PA 19426, US MELLINGER, Mark, Collegeville PA 19426, US XIE, Ren, Collegeville PA 19426, US PENG, Xin, Collegeville PA 19426, US 41 Anmeldungen Applications Demandes (09/2012) 29.02.2012 (74) Reed, Michael Antony, GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road, GB-Brentford, Middlesex TW8 9GS, GB (51) A61K 31/535 (11) 2 421 538 A1* C07D 265/36 (25) En (26) En (21) 10767622.3 (22) 20.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2010/031714 20.04.2010 (87) WO 2010/123870 2010/43 28.10.2010 (30) 20.04.2009 US 426495 (54) HETEROARYLVERBINDUNGEN UND IHRE VERWENDUNG HETEROARYL COMPOUNDS AND USES THEREOF COMPOSÉS HÉTÉROARYLE ET LEURS UTILISATIONS (71) Avila Therapeutics, Inc., 100 Beaver Street, First Floor, Waltham, MA 02453-8425, US (72) SINGH, Juswinder, Ashland MA 01721, US GHOSH, Shomir, Brookline MA 02446, US KLUGE, Arthur, F., Lincoln MA 01773, US PETTER, Russell, C., Stow MA 01775, US TESTER, Richland, Wayne, Marlborough MA 01752, US (74) Tostmann, Holger Carl, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Zweibrückenstrasse 5-7, 80331 München, DE A61K 31/5377 → (51) C07D 401/06 (51) A61K 31/538 (11) 2 421 539 A1* A61K 31/47 A61P 31/00 A61K 9/12 A61P 11/00 (25) En (26) En (21) 10767800.5 (22) 22.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) US 2010/032128 22.04.2010 (87) WO 2010/124141 2010/43 28.10.2010 (30) 24.04.2009 US 172625 P (54) VERFAHREN ZUR BEHANDLUNG EINER BAKTERIELLEN INFEKTION DER LUNGE MITHILFE VON FLUORCHINOLONEN METHODS OF TREATING A PULMONARY BACTERIAL INFECTION USING FLUORO- QUINOLONES MÉTHODES DE TRAITEMENT D'UNE INFECTION PULMONAIRE BACTÉRIENNE UTILISANT DES FLUOROQUINOLONES (71) Mpex Pharmaceuticals, Inc., 11535 Sorrento Valley Road, San Diego, CA 92121-1309, US (72) DUDLEY, Mike, San Diego CA 92127, US GRIFFITH, David, San Marcos CA 92069, US RODNY, Olga, Mountain View CA 94040, US (74) Hart, Deborah Mary, et al, Kilburn & Strode LLP 20 Red Lion Street, London WC1R 4PJ, GB (51) A61K 31/5415 (11) 2 421 540 A1* A61K 9/14 A61P 29/00 (25) En (26) En (21) 10766518.4 (22) 23.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) AU 2010/000469 23.04.2010 (87) WO 2010/121325 2010/43 28.10.2010 (30) 24.04.2009 AU 2009901742 24.04.2009 US 172284 P (54) NEUE MELOXICAMFORMULIERUNG A NOVEL FORMULATION OF MELOXICAM
- Page 1 and 2: Europäisches Patentblatt European
- Page 3 and 4: A I.12 Änderungen und Korrekturen
- Page 5 and 6: A II.12(10) Erfinder 1093 II.12(10)
- Page 7 and 8: B Im Abschnitt III.3 werden die Kor
- Page 9 and 10: C (34) Für prioritätsbegründende
- Page 11 and 12: D D Zusätzliche Angaben D Suppleme
- Page 13 and 14: D Abschnitt I.12(24) Section I.12(2
- Page 15 and 16: D Abschnitt II.10(1) Section II.10(
- Page 17 and 18: I. I. Veröffentlichte europäische
- Page 19 and 20: (A01N) I.1(1) (71) Merck Sharp & Do
- Page 21 and 22: (A23C) I.1(1) (54) MILCHPRODUKT MIT
- Page 23 and 24: (A43B) I.1(1) Tedaldi, William, Via
- Page 25 and 26: (A47D) I.1(1) (72) BERGKVIST, Håka
- Page 27 and 28: (A61B) I.1(1) (71) Advanced Brain M
- Page 29 and 30: (A61B) I.1(1) A61B 17/12 → (51) A
- Page 31 and 32: (A61C) I.1(1) (84) AT BE BG CH CY C
- Page 33 and 34: (A61F) I.1(1) SYSTÈME D'IMPLANTATI
- Page 35 and 36: (A61K) I.1(1) (51) A61K 8/23 (11) 2
- Page 37 and 38: (A61K) I.1(1) (72) PEDERSEN, Kurt,
- Page 39: (A61K) I.1(1) A61K 31/155 → (51)
- Page 43 and 44: (A61K) I.1(1) REPLIKIN-SEQUENCES FO
- Page 45 and 46: (A61K) I.1(1) (74) Bingham, Ian Mar
- Page 47 and 48: (A61M) I.1(1) PULSED ELECTROMAGNETI
- Page 49 and 50: (A61M) I.1(1) (21) 10766506.9 (22)
- Page 51 and 52: (A61N) I.1(1) CONNECTOR WITH TWO PI
- Page 53 and 54: (A61P) I.1(1) A61P 37/02 → (51) A
- Page 55 and 56: (B01D) I.1(1) (86) US 2010/032150 2
- Page 57 and 58: (B01J) I.1(1) (74) Anderson, James
- Page 59 and 60: (B04C) I.1(1) (74) Acapo AS, P.O. B
- Page 61 and 62: (B23B) I.1(1) (51) B23B 27/16 (11)
- Page 63 and 64: (B29B) I.1(1) STRUCTURE FILTRANTE D
- Page 65 and 66: (B32B) I.1(1) CNT-BASED SIGNATURE C
- Page 67 and 68: (B60C) I.1(1) (74) Banzer, Hans-Jö
- Page 69 and 70: (B60T) I.1(1) (71) Robert Bosch Gmb
- Page 71 and 72: (B64C) I.1(1) LONGERON COMPRENANT U
- Page 73 and 74: (B65D) I.1(1) LINDSAY, Brendan Jon,
- Page 75 and 76: (B66B) I.1(1) (54) VERFAHREN ZUR KO
- Page 77 and 78: (C02F) I.1(1) (87) WO 2010/122508 2
- Page 79 and 80: (C07C) I.1(1) (84) AT BE BG CH CY C
- Page 81 and 82: (C07D) I.1(1) C07D 205/06 → (51)
- Page 83 and 84: (C07D) I.1(1) ANTAGONISTES CCR3 D'A
- Page 85 and 86: (C07D) I.1(1) DI FABIO, Romano, 371
- Page 87 and 88: (C07D) I.1(1) FLORES, Christopher,
- Page 89 and 90: (C07F) I.1(1) (84) AT BE BG CH CY C
(A61K) I.1(1)<br />
COMPOSÉS, COMPOSITIONS ET<br />
MÉTHODES COMPRENANT DES DÉRIVÉS<br />
DU 1,3,4-OXADIAZOLE<br />
(71) Institute for OneWorld Health, 280 Utah<br />
Avenue, Suite 250, South San Francisco, CA<br />
94080, US<br />
(72) RUSSELL, Michael Geoffrey Neil, Saffron<br />
Walden, Essex CB10 1XL, GB<br />
DOYLE, Kevin James, Saffron Walden, Essex<br />
CB10 1XL, GB<br />
(74) Gates, Marie Christina Esther, et al, Tomkins<br />
& Co. 5 Dartmouth Road, Dublin 6, IE<br />
A61K 31/41 → (51) A01N 43/82<br />
A61K 31/415 → (51) A61K 9/51<br />
A61K 31/415 → (51) A61K 31/215<br />
A61K 31/415 → (51) C07D 231/14<br />
A61K 31/415 → (51) C07D 231/40<br />
A61K 31/4174 → (51) C07D 233/06<br />
A61K 31/4178 → (51) C07D 403/14<br />
A61K 31/4192 → (51) C07D 231/14<br />
(51) A61K 31/42 (11) 2 421 529 A2*<br />
A61K 31/40 A61K 39/395<br />
A61K 9/16 A61K 9/14<br />
A61P 7/00 A61P 3/00<br />
(25) En (26) En<br />
(21) 10767606.6 (22) 20.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) US 2010/031675 20.04.2010<br />
(87) WO 2010/123845 2010/43 28.10.2010<br />
(88) 17.02.2011<br />
(30) 21.04.20<strong>09</strong> US 171151 P<br />
(54) AUF SIDEROPHORKONJUGAT BASIE-<br />
RENDE IMMUNOGENE ZUSAMMENSET-<br />
ZUNGEN UND IMPFSTOFFE<br />
SIDEROPHORE CONJUGATE IMMU-<br />
NOGENIC COMPOSITIONS AND<br />
VACCINES<br />
COMPOSITIONS IMMUNOGÉNIQUES À<br />
BASE DE CONJUGUÉ SIDÉROPHORE ET<br />
VACCINS<br />
(71) University of Florida Research Foundation,<br />
Inc., 223 Grinter Hall P.O. Box 115500,<br />
Gainesville, FL 32611-5500, US<br />
(72) BERGERON, Raymond, J., Gainesville FL<br />
32604, US<br />
(74) Ilgart, Jean-Christophe, et al, BREVALEX 95<br />
rue d'Amsterdam, 75378 Paris Cedex 8, FR<br />
A61K 31/42 → (51) A61K 31/185<br />
A61K 31/42 → (51) C07D 231/14<br />
(51) A61K 31/421 (11) 2 421 530 A1*<br />
A61K 9/14 A61P 21/02<br />
(25) En (26) En<br />
(21) 10766517.6 (22) 23.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) AU 2010/000468 23.04.2010<br />
(87) WO 2010/121324 2010/43 28.10.2010<br />
(30) 24.04.20<strong>09</strong> AU 20<strong>09</strong>901743<br />
24.04.20<strong>09</strong> US 172281 P<br />
(54) NEUE METAXALONFORMULIERUNG<br />
A NOVEL FORMULATION OF<br />
METAXALONE<br />
NOUVELLE FORMULATION DE MÉTAXA-<br />
LONE<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
(71) Iceutica Pty Ltd., 52 Fairfield Street, Mouth<br />
Hawthorn, WA 6016, AU<br />
(72) DODD, Aaron, Centennial Park New South<br />
Wales 2021, AU<br />
MEISER, Felix, Mount Claremont Western<br />
Australia 6010, AU<br />
NORRET, Marck, Darlington Western<br />
Australia 6070, AU<br />
RUSSELL, Adrian, Rivervale Western<br />
Australia 6103, AU<br />
BOSCH, H William, Bryn Mawr Pennsylvania<br />
19010, US<br />
(74) Coehn, Markus, et al, Fish & Richardson P.C.<br />
Mies-van-der-Rohe-Strasse 8, 80807 München,<br />
DE<br />
A61K 31/421 → (51) A61K 9/14<br />
A61K 31/421 → (51) A61K 9/51<br />
(51) A61K 31/422 (11) 2 421 531 A1*<br />
A61P 15/02 A61P 31/04<br />
A61P 13/02 A61P 15/00<br />
A61K 9/00 A61K 9/06<br />
A61K 9/20<br />
(25) En (26) En<br />
(21) 10715790.1 (22) 19.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
AL BA ME RS<br />
(86) EP 2010/055<strong>09</strong>0 19.04.2010<br />
(87) WO 2010/121980 2010/43 28.10.2010<br />
(30) 20.04.20<strong>09</strong> EP <strong>09</strong>158221<br />
(54) VERWENDUNG VON NIFURATEL ZUR BE-<br />
HANDLUNG VON INFEKTIONEN DURCH<br />
ATOPOBIUM-SPEZIES<br />
USE OF NIFURATEL TO TREAT<br />
INFECTIONS CAUSED BY ATOPOBIUM<br />
SPECIES<br />
UTILISATION DE NIFURATEL POUR<br />
TRAITER DES INFECTIONS PROVOQUÉES<br />
PAR DES ESPÈCES ATOPOBIUM<br />
(71) POLICHEM S.A., 50 Val Fleuri, 1526<br />
Luxembourg, LU<br />
(72) MAILLAND, Federico, CH-6900 Lugano, CH<br />
(74) Pistolesi, Roberto, et al, Dragotti & Associati<br />
Srl Via Nino Bixio, 7, <strong>2012</strong>9 Milano, IT<br />
A61K 31/426 → (51) A61K 31/404<br />
A61K 31/427 → (51) A61K 38/16<br />
A61K 31/433 → (51) A61K 31/155<br />
A61K 31/4353 → (51) A61P 35/00<br />
A61K 31/437 → (51) C07D 493/20<br />
A61K 31/4375 → (51) C07D 471/04<br />
(51) A61K 31/438 (11) 2 421 532 A2*<br />
A61P 13/10 A61P 11/00<br />
(25) En (26) En<br />
(21) <strong>09</strong>818115.9 (22) 01.10.20<strong>09</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) US 20<strong>09</strong>/005441 01.10.20<strong>09</strong><br />
(87) WO 2010/039260 2010/14 08.04.2010<br />
(88) 05.08.2010<br />
(30) 02.10.2008 US 102135 P<br />
(54) SPIPERON-DERIVATE UND VERFAHREN<br />
ZUR BEHANDLUNG VON ERKRANKUN-<br />
GEN<br />
SPIPERONE DERIVATIVES AND<br />
METHODS OF TREATING DISORDERS<br />
DÉRIVÉS DE SPIPÉRONE ET MÉTHODES<br />
DE TRAITEMENT DE TROUBLES<br />
40<br />
Anmeldungen<br />
Applications<br />
Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />
(71) The Johns Hopkins University, 3400 North<br />
Charles Street, Baltimore, MD 21218, US<br />
(72) GUGGINO, William, B., Baltimore MD 21210,<br />
US<br />
SCHWIEBERT, Erik, M., Birmingham, AL<br />
35203, US<br />
LIANG, Lihua, Baltimore MD 21212, US<br />
(74) Hiebl, Inge Elisabeth, Kraus & Weisert <strong>Patent</strong>-<br />
und Rechtsanwälte Thomas-Wimmer-<br />
Ring 15, 80539 München, DE<br />
A61K 31/44 → (51) C07D 401/12<br />
A61K 31/4412 → (51) C07D 213/64<br />
A61K 31/4439 → (51) A61K 31/215<br />
A61K 31/4439 → (51) C07D 513/04<br />
A61K 31/444 → (51) C07D 401/06<br />
A61K 31/444 → (51) C07D 401/12<br />
A61K 31/445 → (51) C07D 211/96<br />
A61K 31/4468 → (51) A61K 31/00<br />
A61K 31/4468 → (51) C07D 211/60<br />
A61K 31/465 → (51) A61K 9/14<br />
(51) A61K 31/47 (11) 2 421 533 A1*<br />
C07D 239/91<br />
(25) En (26) En<br />
(21) 10714825.6 (22) 21.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) US 2010/031870 21.04.2010<br />
(87) WO 2010/123975 2010/43 28.10.2010<br />
(30) 22.04.20<strong>09</strong> US 171620 P<br />
(54) NEUE ENTZÜNDUNGSHEMMENDE MIT-<br />
TEL<br />
NOVEL ANTI-INFLAMMATORY AGENTS<br />
NOUVEAUX AGENTS ANTI-INFLAMMA-<br />
TOIRES<br />
(71) RESVERLOGIX CORP., 202, 279 Midpark<br />
Way S.E., Calgary, Alberta T2X 1M2, CA<br />
(72) HANSEN, Henrik, C., Calgary AB T2L 1E6, CA<br />
WAGNER, Gregory, S., Foster City CA 94404,<br />
US<br />
ATTWELL, Sarah, C., Calgary AB T3B 2K5,<br />
CA<br />
MCLURE, Kevin, G., Calgary AB T2W 4V4,<br />
CA<br />
KULIKOWSKI, Ewelina, B., Calgary AB T3H<br />
4N9, CA<br />
(74) Vossius & Partner, Siebertstrasse 4, 81675<br />
München, DE<br />
A61K 31/47 → (51) A61K 31/538<br />
A61K 31/47<strong>09</strong> → (51) A61K 9/14<br />
A61K 31/4745 → (51) C07D 471/04<br />
A61K 31/4747 → (51) C07D 471/10<br />
A61K 31/485 → (51) A61K 9/50<br />
(51) A61K 31/495 (11) 2 421 534 A1*<br />
A61K 9/08 A61P 25/00<br />
A61P 25/22 A61P 25/24<br />
A61P 25/28<br />
(25) En (26) En<br />
(21) 10714164.0 (22) 16.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR
Change language